SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Jun. 30, 2025

Accounting Policies [Abstract]

Schedule of Estimated Useful Life in Years for Property and Equipment

Estimated Useful Life in Years for Property and Equipment
Diagnostic equipment	5–13
Research, development and demonstration equipment	3-7
Machinery and equipment	2-7
Furniture and fixtures	3-9
Leasehold improvements	5–10
Building	28

Schedule of patient fee revenue - net

Patient Fee Revenue - Net
	For the Years Ended June 30
	2025		2024
Commercial Insurance/ Managed Care	$	4,957,159	$	4,952,712
Medicare/Medicaid		1,160,839		1,138,176
Workers’ Compensation/Personal Injury		19,876,923		20,673,483
Other		7,184,525		7,051,425
Net Patient Fee Revenue	$	33,179,446	$	33,815,796

Schedule of earnings per share

	June 30, 2025
Basic	Total		Common Stock		Class C Common Stock		Class A Preferred   Stock
Numerator:
Net income available to common stockholders	$	8,334,261	$	7,802,352	$	135,467	$	396,443
Denominator:
Weighted average shares outstanding		6,906,803		6,210,852		382,513		313,438
Basic income per common share	$	1.21	$	1.26	$	0.35	$	1.26
Diluted
Denominator:
Weighted average shares outstanding				6,210,852		382,513
Class C Common Stock				127,504		—
Total Denominator for diluted earnings per share				6,338,356		382,513
Diluted income per common share			$	1.23	$	0.35

	June 30, 2024
Basic	Total		Common Stock		Class C Common Stock		Class A Preferred   Stock
Numerator:
Net income available to common stockholders	$	10,567,396	$	9,908,920	$	167,700	$	490,776
Denominator:
Weighted average shares outstanding		7,046,959		6,351,008		382,513		313,438
Basic income per common share	$	1.50	$	1.56	$	0.44	$	1.57
Diluted
Denominator:
Weighted average shares outstanding				6,351,008		382,513
Class C Common Stock				127,504		—
Total Denominator for diluted earnings per share				6,478,512		382,513
Diluted income per common share			$	1.53	$	0.44